LONDON, August 30, 2013 /PRNewswire/ --

The U.S. equity market posted gains on Thursday, August 29, 2013, with all three benchmark indexes ending the day on a higher note. The Dow Jones Industrial Average closed at 14,840.95, up 0.11%; the S&P 500 closed at 1,638.17, up 0.20%; and the NASDAQ Composite finished at 3,620.30, up 0.75%. Shares in the healthcare sector ended mostly higher, as the broader market advanced. The major movers in the sector included Life Technologies Corporation (NASDAQ: LIFE), Opko Health Inc. (NYSE: OPK), The Medicines Company (NASDAQ: MDCO), and DaVita HealthCare Partners Inc. (NYSE: DVA). AAAResearchReports.com has released full comprehensive research on LIFE, OPK, MDCO, and DVA. These free technical analyses can be downloaded by signing up at:

http://www.aaaresearchreports.com/register/  

Shares in Life Technologies Corporation edged higher on Thursday, reversing losses from the previous trading sessions. The company's shares closed at $74.49, up 0.31%, after oscillating between $74.26 and $74.55. A total of 1.28 million shares were traded, which is below the daily average volume of 2.05 million. The company's shares have gained 0.32% in the last three months, compared to a loss of 0.62% in the S&P 500 during the same period. Further, Life Technologies Corporation's stock is trading near its 52-week high of $74.98 and also above its 50-day and 200-day moving averages. A free technical analysis on LIFE available by signing up at:

http://www.AAAResearchReports.com/LIFE083013.pdf

On Thursday, Opko Health Inc.'s stock fell sharply, even as the broader market posted gains. The company's stock closed the day at $8.49, which is 1.05% lower than the previous day's closing price of $8.58. The company's shares traded between $8.03 and $8.55. A total of 10.68 million shares were traded, which is significantly above the daily average volume of 1.78 million. Opko Health Inc.'s shares have gained 11.56% in the last one month and 26.34% in the last three months, outperforming the S&P 500 which has fallen by 2.80% and 0.62% during the respective periods. Moreover, the company's stock is trading above its 50-day and 200-day moving averages. Register today and access free research on OPK at:

http://www.AAAResearchReports.com/OPK083013.pdf

On Thursday, the Medicines Company's shares rallied 4.45% to end the day at $32.15. The company's stock fluctuated between $30.72 and $32.27. A total of 0.82 million shares were traded, which is below the daily average volume of 0.85 million. The company's shares have gained 4.45% in the last one month, compared to a loss of 2.80% in the S&P 500 during the same period. Additionally, the Medicines Company's stock is trading above its 50-day and 200-day moving averages. The free report on MDCO can be downloaded by signing up now at:

http://www.AAAResearchReports.com/MDCO083013.pdf

Shares in DaVita HealthCare Partners Inc. finished flat on Thursday, even as the broader market posted gains. The company's shares fluctuated between $107.76 and $109.59 before ending the day at the previous day's closing price of $108.02. A total of 0.83 million shares were traded, which is below the daily average volume of 0.85 million. The company's stock has fallen by 7.58% in the last one month, compared to a decline of 2.80% in the S&P 500 during the same period. Further, the company's shares are trading below its 50-day and 200-day moving averages. A free report on DVA can be accessed by registering at:

http://www.AAAResearchReports.com/DVA083013.pdf

----

EDITOR NOTES:

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is fact checked and produced on a best efforts basis and reviewed by a CFA ® charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
5. For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider has, through Chartered Financial Analysts, only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

AAAresearchreports.com

SOURCE AAA Research Reports